Lamotrigin Hexal

Lamotrigine, the active ingredient in Lamotrigin Hexal, is an antiepileptic presented as an oral formulation for oral use. It is indicated for the treatment of epilepsy and for mood stabilization in bipolar disorder.

GNH USA supplies Lamotrigin Hexal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamotrigine is used in the management of seizure disorders and mood stabilization. - Epilepsy (partial seizures): reduces the frequency of focal seizures. - Epilepsy (generalized seizures): helps control tonic‑clonic and absence seizures. - Bipolar disorder: stabilises mood and reduces the risk of depressive and manic episodes.

Lamotrigin Hexal may be associated with a range of adverse reactions.

Common Side Effects: - Rash or skin irritation - Dizziness or light‑headedness - Headache - Nausea or gastrointestinal upset - Insomnia or sleep disturbances - Blurred vision

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Severe skin reactions (e.g., maculopapular rash with systemic symptoms) - Blood dyscrasias such as agranulocytosis or aplastic anemia - Hepatic failure or severe liver injury - Suicidal thoughts or behavior - Severe hypersensitivity reactions (e.g., anaphylaxis)

When prescribing Lamotrigin Hexal, clinicians should consider several safety measures. - Dose titration: increase gradually to minimise rash risk. - Skin monitoring: inspect regularly for any rash or hypersensitivity. - Hepatic function: evaluate in patients with liver disease. - Renal function: adjust if severe impairment is present. - Pregnancy: discuss limited safety data and potential risks. - Store at ambient temperature: keep in the original pack, protect from moisture.

Lamotrigine can interact with other medicines, affecting its concentration or safety.

Major Interactions (Avoid): - Valproic acid: markedly increases lamotrigine levels, raising toxicity risk. - Carbamazepine: reduces lamotrigine concentrations, potentially decreasing efficacy. - Phenobarbital: lowers lamotrigine levels, may require dose adjustment. - Phenytoin: decreases lamotrigine exposure, affecting seizure control. - Oral contraceptives: increase lamotrigine clearance, possibly reducing effectiveness.

Moderate Interactions (Monitor Closely): - Serotonergic agents: potential for serotonin syndrome. - Other antiepileptics (e.g., gabapentin): may need therapeutic monitoring. - Antidepressants (e.g., SSRIs): watch for mood changes. - Immunosuppressants: monitor for altered metabolism. - Alcohol: may enhance central nervous system depression.